川發龍蟒(002312.SZ):上半年淨利預降68.27%-73.35%
格隆匯7月14日丨川發龍蟒(002312.SZ)公佈2023年半年度業績預吿,報吿期歸屬於上市公司股東的淨利潤盈利21,000萬元—25,000萬元,比上年同期下降68.27%—73.35%;歸屬於上市公司股東的扣除非經常性損益後的淨利潤盈利17,000萬元—21,000萬元,比上年同期下降69.56%—75.36%;基本每股收益盈利0.11元/股—0.13元/股。
報吿期內,受磷化工行業景氣週期下行、供需錯配等不利影響,公司主要產品價格持續下跌,產銷量有所下滑,核心產品盈利能力減弱,多重因素導致公司本報吿期營業收入、淨利潤、基本每股收益同比下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.